JP2012521411A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012521411A5 JP2012521411A5 JP2012501503A JP2012501503A JP2012521411A5 JP 2012521411 A5 JP2012521411 A5 JP 2012521411A5 JP 2012501503 A JP2012501503 A JP 2012501503A JP 2012501503 A JP2012501503 A JP 2012501503A JP 2012521411 A5 JP2012521411 A5 JP 2012521411A5
- Authority
- JP
- Japan
- Prior art keywords
- formula
- compound
- represented
- vii
- nitrogen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 150000001875 compounds Chemical class 0.000 claims 24
- 238000000034 method Methods 0.000 claims 18
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims 6
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 claims 6
- 125000000467 secondary amino group Chemical group [H]N([*:1])[*:2] 0.000 claims 6
- 125000000008 (C1-C10) alkyl group Chemical group 0.000 claims 4
- 239000003153 chemical reaction reagent Substances 0.000 claims 4
- 229910052757 nitrogen Inorganic materials 0.000 claims 4
- 150000003839 salts Chemical class 0.000 claims 4
- 239000011780 sodium chloride Substances 0.000 claims 4
- 239000002253 acid Substances 0.000 claims 3
- WPYMKLBDIGXBTP-UHFFFAOYSA-M benzoate Chemical group [O-]C(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-M 0.000 claims 3
- 238000006243 chemical reaction Methods 0.000 claims 3
- 150000004985 diamines Chemical class 0.000 claims 3
- 229910052736 halogen Inorganic materials 0.000 claims 3
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 3
- ZSBOMTDTBDDKMP-OAHLLOKOSA-N Alogliptin Chemical compound C=1C=CC=C(C#N)C=1CN1C(=O)N(C)C(=O)C=C1N1CCC[C@@H](N)C1 ZSBOMTDTBDDKMP-OAHLLOKOSA-N 0.000 claims 2
- FEWJPZIEWOKRBE-JCYAYHJZSA-L L-tartrate(2-) Chemical group [O-]C(=O)[C@H](O)[C@@H](O)C([O-])=O FEWJPZIEWOKRBE-JCYAYHJZSA-L 0.000 claims 2
- XHXFXVLFKHQFAL-UHFFFAOYSA-N Phosphoryl chloride Chemical compound ClP(Cl)(Cl)=O XHXFXVLFKHQFAL-UHFFFAOYSA-N 0.000 claims 2
- FYSNRJHAOHDILO-UHFFFAOYSA-N Thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 claims 2
- ISAKRJDGNUQOIC-UHFFFAOYSA-N Uracil Chemical compound O=C1C=CNC(=O)N1 ISAKRJDGNUQOIC-UHFFFAOYSA-N 0.000 claims 2
- 150000002148 esters Chemical class 0.000 claims 2
- 150000002367 halogens Chemical class 0.000 claims 2
- OFOBLEOULBTSOW-UHFFFAOYSA-N malonic acid Chemical compound OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 claims 2
- 125000006239 protecting group Chemical group 0.000 claims 2
- 125000001424 substituent group Chemical group 0.000 claims 2
- 229940086735 succinate Drugs 0.000 claims 2
- KDYFGRWQOYBRFD-UHFFFAOYSA-L succinate(2-) Chemical group [O-]C(=O)CCC([O-])=O KDYFGRWQOYBRFD-UHFFFAOYSA-L 0.000 claims 2
- JVTAAEKCZFNVCJ-REOHCLBHSA-M (S)-lactate Chemical group C[C@H](O)C([O-])=O JVTAAEKCZFNVCJ-REOHCLBHSA-M 0.000 claims 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K 2qpq Chemical group [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 claims 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N HCl Chemical group Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims 1
- PCLIMKBDDGJMGD-UHFFFAOYSA-N N-Bromosuccinimide Chemical compound BrN1C(=O)CCC1=O PCLIMKBDDGJMGD-UHFFFAOYSA-N 0.000 claims 1
- UHZYTMXLRWXGPK-UHFFFAOYSA-N Phosphorus pentachloride Chemical compound ClP(Cl)(Cl)(Cl)Cl UHZYTMXLRWXGPK-UHFFFAOYSA-N 0.000 claims 1
- IPNPIHIZVLFAFP-UHFFFAOYSA-N Phosphorus tribromide Chemical compound BrP(Br)Br IPNPIHIZVLFAFP-UHFFFAOYSA-N 0.000 claims 1
- DTQVDTLACAAQTR-UHFFFAOYSA-M Trifluoroacetate Chemical group [O-]C(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-M 0.000 claims 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M acetate Chemical group CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 claims 1
- 125000000217 alkyl group Chemical group 0.000 claims 1
- 125000005466 alkylenyl group Chemical group 0.000 claims 1
- 229960001667 alogliptin Drugs 0.000 claims 1
- 229960000447 alogliptin benzoate Drugs 0.000 claims 1
- KEJICOXJTRHYAK-XFULWGLBSA-N alogliptin benzoate Chemical compound OC(=O)C1=CC=CC=C1.C=1C=CC=C(C#N)C=1CN1C(=O)N(C)C(=O)C=C1N1CCC[C@@H](N)C1 KEJICOXJTRHYAK-XFULWGLBSA-N 0.000 claims 1
- 230000015572 biosynthetic process Effects 0.000 claims 1
- 229910052794 bromium Inorganic materials 0.000 claims 1
- 229910052801 chlorine Inorganic materials 0.000 claims 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims 1
- 229910052731 fluorine Inorganic materials 0.000 claims 1
- 125000005843 halogen group Chemical group 0.000 claims 1
- 229910052740 iodine Inorganic materials 0.000 claims 1
- 150000002500 ions Chemical class 0.000 claims 1
- 150000002690 malonic acid derivatives Chemical class 0.000 claims 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 1
- 125000006217 methyl sulfide group Chemical group [H]C([H])([H])S* 0.000 claims 1
- OFOBLEOULBTSOW-UHFFFAOYSA-L propanedioate Chemical compound [O-]C(=O)CC([O-])=O OFOBLEOULBTSOW-UHFFFAOYSA-L 0.000 claims 1
- 238000000746 purification Methods 0.000 claims 1
- 150000008512 pyrimidinediones Chemical class 0.000 claims 1
- 238000000926 separation method Methods 0.000 claims 1
- -1 succinimidyl ester Chemical class 0.000 claims 1
- 238000003786 synthesis reaction Methods 0.000 claims 1
- 230000002194 synthesizing Effects 0.000 claims 1
- WUOQXNWMYLFAHT-MRVPVSSYSA-N tert-butyl N-[(3R)-piperidin-3-yl]carbamate Chemical compound CC(C)(C)OC(=O)N[C@@H]1CCCNC1 WUOQXNWMYLFAHT-MRVPVSSYSA-N 0.000 claims 1
- 150000003672 ureas Chemical class 0.000 claims 1
- 0 *C(C(N(*)C(N1*)=O)=O)C1=O Chemical compound *C(C(N(*)C(N1*)=O)=O)C1=O 0.000 description 1
- NSUJZKVLZDWMQP-UHFFFAOYSA-N CN(C(CC#N)=O)C(NCc1ccccc1C#N)=O Chemical compound CN(C(CC#N)=O)C(NCc1ccccc1C#N)=O NSUJZKVLZDWMQP-UHFFFAOYSA-N 0.000 description 1
- PAMIQIKDUOTOBW-UHFFFAOYSA-N CN1CCCCC1 Chemical compound CN1CCCCC1 PAMIQIKDUOTOBW-UHFFFAOYSA-N 0.000 description 1
Claims (19)
- 化学式(I)の構造によって表される、ピリミジンジオン誘導体の製造プロセスであって、
R1及びR5は、それぞれ独立的にHまたは(C1〜C10)アルキルであり、
R2はCH2Arであり、また
R3及びR4は、窒素と共に結合して、4、5、6、または7員環を形成し、それは非置換でも置換でもよく、
前記プロセスは、
1)化学式(VIII)の尿素誘導体を
- Xが、ハロゲン(F、Cl、Br、I)、OTs、OMs、SMe、SPh、Im、Bta、及びNH2から選択される、請求項1に記載のプロセス。
- 化学式(III)のHNR3R4は、化学式(V)HNR6R7−NHR8のジアミンであり、式中、R6及びR7は窒素と共に結合して、4、5、6または7員環を形成し、NHR8は、そのような環の置換基であり、R8はHまたは窒素保護基である、請求項1に記載のプロセス。
- (a)化学式(II)の化合物と、化学式(V)のジアミンとを、化合物(VI)が十分に形成される条件下で反応させるステップ、
(b)化合物(VI)を酸HYと反応させて、化合物(VI)の分離および精製なしに一段階合成で塩を形成するステップ、及び
(c)任意で、もし必要である場合、化学式(I)の化合物を形成するために前記保護基を取り除くステップ、
を含む、請求項7または8に記載のプロセス。 - 前記保護基が、ステップ(b)において酸HYで処理する際に取り除かれ、かつステップ(c)が実施されない、請求項9に記載のプロセス。
- 前記化学式(I)の前記ピリミジンジオンが、2−[6−[3(R)−アミノピペリジン−1−イル]−3−メチル−2,4−ジオキソ−1,2,3,4−テトラヒドロピリミジン−1−イルメチル]ベンゾニトリル(アログリプチン)またはその塩である、請求項1〜11のいずれか1項に記載のプロセス。
- 前記塩が、安息香酸塩(安息香酸アログリプチン)である、請求項12に記載のプロセス。
- 前記マロン酸誘導体が、マロン酸エステルであり、前記エステルが、メチル、エチル、非置換または置換フェニル、またはN−オキシスクインイミジルエステルである、請求項1に記載のプロセス。
- 請求項1に記載のプロセスに従って調製される、化学式(I)の化合物、または請求項3に記載のプロセスに従って調製される、化学式(IV)の化合物。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US16348109P | 2009-03-26 | 2009-03-26 | |
US61/163,481 | 2009-03-26 | ||
PCT/IL2010/000260 WO2010109468A1 (en) | 2009-03-26 | 2010-03-25 | Process for the preparation of alogliptin |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2012521411A JP2012521411A (ja) | 2012-09-13 |
JP2012521411A5 true JP2012521411A5 (ja) | 2013-05-02 |
Family
ID=42780220
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2012501503A Pending JP2012521411A (ja) | 2009-03-26 | 2010-03-25 | アログリプチンの調製プロセス |
Country Status (9)
Country | Link |
---|---|
US (1) | US8841447B2 (ja) |
EP (1) | EP2410855B1 (ja) |
JP (1) | JP2012521411A (ja) |
CN (1) | CN102361557A (ja) |
AU (1) | AU2010228902A1 (ja) |
BR (1) | BRPI1013561A8 (ja) |
CA (1) | CA2755561A1 (ja) |
MX (1) | MX2011010079A (ja) |
WO (1) | WO2010109468A1 (ja) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20130317251A1 (en) | 2011-02-10 | 2013-11-28 | Solvay Sa | Process for the manufacture of fluoromethoxymalonic acid derivatives |
WO2013046229A1 (en) * | 2011-09-26 | 2013-04-04 | Hetero Research Foundation | Novel salts of alogliptin |
CN102942556A (zh) * | 2012-12-04 | 2013-02-27 | 成都天翼医药科技有限公司 | 一种苯甲酸阿格列汀的制备工艺 |
CN103910710B (zh) * | 2012-12-29 | 2017-06-16 | 乳源东阳光药业有限公司 | 阿格列汀新晶型及其制备方法 |
CN103193762B (zh) * | 2013-03-29 | 2015-07-29 | 山东罗欣药业集团股份有限公司 | 苯甲酸阿格列汀的制备方法 |
US9776985B2 (en) | 2013-05-24 | 2017-10-03 | Glenmark Pharmaceuticals Limited | Process for preparation of alogliptin |
CN104447685A (zh) * | 2013-09-23 | 2015-03-25 | 上海天慈生物谷生物工程有限公司 | 一种阿洛利汀的制备方法 |
WO2015092739A1 (en) * | 2013-12-19 | 2015-06-25 | Mylan Laboratories Ltd. | Process for preparation of alogliptin |
CN105085475B (zh) * | 2014-05-09 | 2019-05-21 | 上海科胜药物研发有限公司 | 一种合成阿格列汀中间体的方法 |
CN104086527B (zh) * | 2014-07-03 | 2016-09-21 | 湖南欧亚生物有限公司 | 一种苯甲酸阿格列汀的合成方法 |
CN105315256B (zh) * | 2014-07-07 | 2018-02-06 | 广州朗圣药业有限公司 | 一种适合工业化的高纯度琥珀酸曲格列汀的制备方法 |
CN105777709A (zh) * | 2014-12-22 | 2016-07-20 | 上海医药工业研究院 | 阿格列汀的制备工艺 |
EP3292112B1 (en) | 2015-05-04 | 2019-08-14 | Indoco Remedies Limited | Process for the preparation of alogliptin |
CN104961726A (zh) * | 2015-06-19 | 2015-10-07 | 浙江永宁药业股份有限公司 | 一种曲格列汀的制备方法 |
CN105801490B (zh) * | 2016-05-05 | 2019-08-23 | 傅晓倩 | 一种制备阿格列汀中间体的方法 |
CN105837557A (zh) * | 2016-05-05 | 2016-08-10 | 青岛辰达生物科技有限公司 | 一种用于治疗ii型糖尿病的阿格列汀的制备方法 |
CN105968091A (zh) * | 2016-05-05 | 2016-09-28 | 青岛辰达生物科技有限公司 | 一种制备治疗ii型糖尿病药物阿格列汀的方法 |
CN107311940B (zh) * | 2017-07-26 | 2019-08-30 | 中国人民解放军第三军医大学 | 一种嘧啶二酮类化合物的制备方法 |
CN110128401B (zh) * | 2018-02-02 | 2020-04-28 | 新发药业有限公司 | 一种苯甲酸阿格列汀的简便制备方法 |
CN109232443B (zh) * | 2018-10-29 | 2022-03-08 | 中国药科大学 | 嘧啶酮衍生物、其制备方法及医药用途 |
CN114057685A (zh) * | 2020-07-31 | 2022-02-18 | 西安新通药物研究有限公司 | 一种高收率苯甲酸阿格列汀的制备方法 |
CN114105889B (zh) * | 2021-12-16 | 2023-06-13 | 山东创新药物研发有限公司 | 一种dpp-iv抑制剂关键中间体的制备方法及其应用 |
Family Cites Families (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8031A (en) * | 1851-04-08 | Gkraih separator and ban | ||
US2598936A (en) * | 1950-04-13 | 1952-06-03 | Searle & Co | Disubstituted cyanoalkanoylureas and thioureas and methods for their production |
US4089959A (en) * | 1976-03-31 | 1978-05-16 | Cooper Laboratories, Inc. | Long-acting xanthine bronchodilators and antiallergy agents |
DE4114238A1 (de) * | 1991-04-26 | 1992-10-29 | Zentralinstitut Fuer Organisch | Neue substituierte 2,2 -pentamethylen-(delta)(pfeil hoch)3(pfeil hoch)-imidazolin-5-one bzw. 2,2 -pentamethylen-imidazolidin-5-one und verfahren zu deren herstellung |
TW252044B (ja) * | 1992-08-10 | 1995-07-21 | Boehringer Ingelheim Kg | |
JPH08319288A (ja) * | 1994-06-20 | 1996-12-03 | Takeda Chem Ind Ltd | 縮合イミダゾール誘導体、その製造法及び剤 |
CA2206287C (en) * | 1994-12-13 | 2001-03-20 | Mark Chasin | Aryl thioxanthines |
US6248746B1 (en) * | 1998-01-07 | 2001-06-19 | Euro-Celtique S.A. | 3-(arylalkyl) xanthines |
MXPA00012647A (es) * | 1998-05-26 | 2003-07-14 | Natural Drug Sciences Llc | Derivados n-sustituidos de acido 5-oxiiminobarbiturico. |
WO2001029010A1 (en) * | 1999-10-21 | 2001-04-26 | Merck & Co., Inc. | Gram-positive selective antibacterial compounds, compositions containing such compounds and methods of treatment |
GB0008694D0 (en) * | 2000-04-07 | 2000-05-31 | Novartis Ag | Organic compounds |
US20080194593A1 (en) | 2001-11-09 | 2008-08-14 | Rao Kalla | A2b adenosine receptor antagonists |
US7407955B2 (en) | 2002-08-21 | 2008-08-05 | Boehringer Ingelheim Pharma Gmbh & Co., Kg | 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions |
CN102134230B (zh) | 2004-03-15 | 2019-06-28 | 武田药品工业株式会社 | 二肽基肽酶抑制剂 |
CN1926128A (zh) * | 2004-03-15 | 2007-03-07 | 武田药品工业株式会社 | 二肽基肽酶抑制剂 |
CN101006086B (zh) | 2004-06-11 | 2010-09-29 | 日本烟草产业株式会社 | 用于治疗癌症的5-氨基-2,4,7-三氧代-3,4,7,8-四氢-2H-吡啶并[2,3-d]嘧啶衍生物和相关化合物 |
US7378423B2 (en) * | 2004-06-11 | 2008-05-27 | Japan Tobacco Inc. | Pyrimidine compound and medical use thereof |
AU2006229791A1 (en) * | 2005-03-24 | 2006-10-05 | Janssen Pharmaceutica, N.V. | Pyrimidindione derivatives as prokineticin 2 receptor antagonists |
TW200745080A (en) | 2005-09-16 | 2007-12-16 | Takeda Pharmaceuticals Co | Polymorphs of tartrate salt of 2-[2-(3-(R)-amino-piperidin-1-yl)-5-fluoro-6-oxo-6H-pyrimidin-1-ylmethyl]-benzonitrile and methods of use therefor |
CN102675221A (zh) * | 2005-09-16 | 2012-09-19 | 武田药品工业株式会社 | 用于制备嘧啶二酮衍生物的方法中的中间体 |
TW200745079A (en) | 2005-09-16 | 2007-12-16 | Takeda Pharmaceuticals Co | Polymorphs of benzoate salt of 2-[[6-[(3R)-3-amino-1-piperidinyl]-3,4-dihydro-3-methyl-2,4-dioxo-1(2H)-pyrimidinyl]methyl]-benzonitrile and methods of use therefor |
GB0605785D0 (en) * | 2006-03-22 | 2006-05-03 | Glaxo Group Ltd | Compounds |
AR061570A1 (es) | 2006-06-23 | 2008-09-03 | Smithkline Beecham Corp | Compuesto de glicina sustituido en el n heteroaromatico composicion farmaceutica que lo comprende, su uso para preparar un medicamento, procedimientos para preparar dicha composicion farmaceutica y para preparar el compuesto |
TW200838536A (en) | 2006-11-29 | 2008-10-01 | Takeda Pharmaceutical | Polymorphs of succinate salt of 2-[6-(3-amino-piperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethy]-4-fluor-benzonitrile and methods of use therefor |
NZ583346A (en) | 2007-07-19 | 2012-02-24 | Takeda Pharmaceutical | Solid preparation comprising alogliptin and metformin hydrochloride |
WO2010089686A1 (en) | 2009-02-04 | 2010-08-12 | Pfizer Inc. | 4-amino-7,8-dihydropyrido[4,3-d]pyrimidin-5(6h)-one derivatives |
-
2010
- 2010-03-25 AU AU2010228902A patent/AU2010228902A1/en not_active Abandoned
- 2010-03-25 JP JP2012501503A patent/JP2012521411A/ja active Pending
- 2010-03-25 CA CA2755561A patent/CA2755561A1/en not_active Abandoned
- 2010-03-25 BR BRPI1013561A patent/BRPI1013561A8/pt not_active IP Right Cessation
- 2010-03-25 WO PCT/IL2010/000260 patent/WO2010109468A1/en active Application Filing
- 2010-03-25 EP EP10755533.6A patent/EP2410855B1/en active Active
- 2010-03-25 MX MX2011010079A patent/MX2011010079A/es not_active Application Discontinuation
- 2010-03-25 CN CN2010800136497A patent/CN102361557A/zh active Pending
- 2010-03-25 US US13/258,816 patent/US8841447B2/en not_active Expired - Fee Related
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2012521411A5 (ja) | ||
JP6647268B2 (ja) | ハロゲン化環式化合物の合成方法 | |
JP2013523887A5 (ja) | ||
JP6488359B2 (ja) | ベンズイミダゾール誘導体の製造方法 | |
JP2014510774A5 (ja) | ||
JP2017504576A5 (ja) | ||
JP2012515142A5 (ja) | ||
JP2008533191A5 (ja) | ||
JP2011524871A5 (ja) | ||
JP2013500304A5 (ja) | ||
JP2008063336A5 (ja) | ||
JP2013518111A5 (ja) | ||
TW201040152A (en) | Method for preparing ascorbic acid derivatives | |
JP2011503053A (ja) | 2‐ヒドロキシ‐5‐フェニルアルキルアミノ安息香酸誘導体及びその塩の製造方法 | |
US20100292482A1 (en) | Novel precursors | |
JP2010511047A5 (ja) | ||
JP2013530948A5 (ja) | ||
JP2006528215A5 (ja) | ||
JP2011511053A (ja) | ボリノスタットの新規な製造方法 | |
JP2015514729A5 (ja) | ||
JP2010207786A (ja) | アルカリ土類金属系触媒、及び反応方法 | |
JP2005041802A (ja) | 1,2,4−トリアゾール化合物の製造方法 | |
JP2010512392A5 (ja) | ||
JP2018510218A5 (ja) | ||
JP4667575B2 (ja) | 1,3−ジアルキルイミダゾリウムヨウ素塩の製造方法 |